← Leaderboards
Matthew Scott Kelly
Duke University
$2,764,525
Attributed
$5,660,762
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,660,762 · 4
By mechanism
R01$4,014,793 · 1
K23$859,553 · 1
R21$786,416 · 2
Top collaborators
- Genevieve Giny Fouda Amou Ou5 shared
- Sallie R. Permar5 shared
- Patrick C. Seed2 shared
Most similar at Duke University
Same institution · by research overlap
- Barton F Haynes$531,570,874
- Zachary Conrad Hartman$2,643,521
- Genevieve Giny Fouda Amou Ou$19,482,405
- Patrick C. Seed$6,283,538
- Md, Kanecia Zimmerman$5,999,956
Others in their field
Other Emerging Leaders on “Cessation Of Life”
- Xinhua Li · Nano Terra, Inc.$32,520,955
- Christopher Barnaby Nelson · University Of Melbourne$27,954,628
- Abraham Aizer Brody · New York University School Of Medicine$21,799,826
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$20,810,724
- Jeffrey Reich · Sparian Biosciences, Inc.$20,633,040
- Beth Baseler · Leidos Biomedical Research, Inc.$18,109,529
Research focus
Cessation Of LifeInfectionPreventRespiratory VirusSamplingInsightPathogenChildhoodChildPreventionDesignGenomicsVaccinesGenesStreptococcus PneumoniaeProbioticsUpper Respiratory TractVaccinationLower Respiratory Tract StructureMicrobiome2019-NcovImmunityInflammatoryMonoclonal Antibodies
Grant awards (14)
Early life B cell responses and inflammation following SARS-CoV-2 infection$838,453
R01 · FY2025 · AI
Early life B cell responses and inflammation following SARS-CoV-2 infection$852,895
R01 · FY2024 · AI
Host-microbe interactions and SARS-CoV-2 susceptibility and symptoms in a novel human challenge model$105,500
R21 · FY2024 · AI · contact PI
Early life B cell responses and inflammation following SARS-CoV-2 infection$706,463
R01 · FY2023 · AI
Host-microbe interactions and SARS-CoV-2 susceptibility and symptoms in a novel human challenge model$241,500
R21 · FY2023 · AI · contact PI
Rational identification of Corynebacterium strains for use as probiotics$194,300
R21 · FY2023 · AI
Early life B cell responses and inflammation following SARS-CoV-2 infection$762,710
R01 · FY2022 · AI
Rational identification of Corynebacterium strains for use as probiotics$245,116
R21 · FY2022 · AI
Nasopharyngeal Microbiome and Risk of Bacterial Pathogen Colonization in Infants$143,496
K23 · FY2022 · AI · contact PI
Early life B cell responses and inflammation following SARS-CoV-2 infection$854,272
R01 · FY2021 · AI
Nasopharyngeal Microbiome and Risk of Bacterial Pathogen Colonization in Infants$162,314
K23 · FY2021 · AI · contact PI
Nasopharyngeal Microbiome and Risk of Bacterial Pathogen Colonization in Infants$182,233
K23 · FY2020 · AI · contact PI
Nasopharyngeal Microbiome and Risk of Bacterial Pathogen Colonization in Infants$184,181
K23 · FY2019 · AI · contact PI
Nasopharyngeal Microbiome and Risk of Bacterial Pathogen Colonization in Infants$187,329
K23 · FY2018 · AI · contact PI